Download PDF
Hamostaseologie 2017; 37(04): 237
DOI: 10.1055/s-0037-1619835
Editorial
Schattauer GmbH

Update: Direct oral anticoagulants (DOAC) – their use and clinical management remain a challenge

Edelgard Lindhoff-Last Prof. Dr.
1   Cardioangiology Center Bethanien Hospital (CCB), CCB Vascular Center, CCB Coagulation Center, CCB Coagulation Research Center, Frankfurt, Germany
,
Rüdiger E. Scharf
2   Division of Experimental and Clinical Hemostasis, Hemotherapy and Transfusion Medicine, and Hemophilia Comprehensive Care Center, Institute of Transplantation Diagnostics and Cell Therapy, Heinrich Heine University Medical Center, Düsseldorf, Germany
› Author Affiliations
Further Information

Publication History

received: 18 September 2017

accepted: 19 September 2017

Publication Date:
28 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Voigtlaender M, Langer F. Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism – what do we know so far?. Hämostaseologie 2017; 37: 241-255.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Lindhoff-Last E. Direct oral anticoagulants – Management of emergency situations – Rationale and design of the RADOA-registry. Hämostaseologie 2017; 37: 257-266.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Koscielny J, Rosenthal C, von Heymann C. Update on direct oral anticoagulants: perioperative “switching”, drug interactions and persistence. Hämostaseologie 2017; 37: 267-275.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Benetos G, Bonou M, Toutouzas K, Diamantopoulos P, Viniou N, Barbetseas J. Advances in antico-Prof. Dr. Edelgard Lindhoff-Last Cardioangiology Center Bethanien Hospital (CCB), CCB Vascular Center, CCB Coagulation Center, CCB Coagulation Research Center, Frankfurt, Germany agulation management of patients undergoing cardioversion of nonvalvular atrial fibrillation. Hämostaseologie 2017; 37: 277-285.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Kücükköylü S, Rump LC. Update Direct oral anticoagulants – use in patients with chronic kidney disease with or without dialysis. Hämostaseologie 2017; 37: 286-294.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Gosselin RC, Douxfils J, Adcock D. Clinical perls: Laboratory assessment of direct oral anticoagulants. Hämostaseologie 2017; 37: 295-301.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Göndör G, Stöllberger C. Pulmonary embolism four days after interruption of therapy with rivaroxaban. Hämostaseologie 2017; 37: 302-306.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Konstantinides SV. The risks of interrupting anticoagulation. Hämostaseologie 2017; 37: 239-240.
    PubMedGoogle Scholar